Could Existing Immunotherapy Drugs Also Fight ... - CLL Support

CLL Support

23,094 members39,666 posts

Could Existing Immunotherapy Drugs Also Fight CLL? (Patient Power video with Dr John Gribben)

AussieNeil profile image
AussieNeilPartnerAdministrator
0 Replies

Andrew Schorr interviews Dr John Gribben of London's Barts Cancer Institute on the promise of drugs for PD1 and PDL1 that could train the immune system to kill cancer cells.

patientpower.info/video/cou...

I found this video particularly interesting because it covers one of proposed mechanisms by which cancerous B-Lymphocytes mediate the immune dysfunction via their control of T-cells by expressing PDL1 and how existing PD1 and PDL1 antibodies developed for solid tumours might be used to tackle CLL.

Lots of promise here, with plenty of potential tie in with existing and trial treatment regimens, but no indication of any funding for CLL unfortunately...

Neil

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Dr Peter Hillmen of Leeds, UK discusses the place for Idelalisib in CLL treatment (Patient Power Video)

In this short video taken at iwCLL Collogne Germany, Andrew Schorr interviews Dr Hillmen: "As a...

Video interviews; CLL 'Hot Topics and Maturing Data' ASH 2019: Prof John Gribben, Prof Pete Hillmen, Dr George Follows & Dr Renata Walewska

In December, the Leukaemia Care Patient Advocacy team attended the annual American Society of...

Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD

In this Patient Power video - Dr. Brown is very clear about the advantages of Zanubrutinib over...

Venetoclax for dummies

Venetoclax owes its origin to a lady named Eliza Hall, I bet AussieNeil has heard of her. Eliza...

BBC News - 18/04 - Breakthrough in leukaemia treatment (Prof Chris Pepper of Cardiff University on Ibrutinib)

Scientists helped to develop drugs which target the disease at a molecular level By Carwyn Jones...